Ms Lynn Cawkwell

Senior Lecturer in Cancer Genetics

  • 2012 Senior Lecturer, Department of Biological Sciences, University of Hull.

  • 2003 to 2012 Senior Lecturer, Postgraduate Medical Institute, University of Hull.

  • 1999 to 2003 Lecturer, Postgraduate Medical Institute, University of Hull.

  • 1998 to 1999 Research Fellow, Molecular Oncology, Algernon Firth Institute of Pathology, University of Leeds.

  • 1992 to 1998 Research Assistant, Molecular Oncology, Algernon Firth Institute of Pathology, University of Leeds.

  • 1988 to 1992 Scientific Officer, CRC Department of Carcinogenesis, Paterson Institute for Cancer Research, Manchester.

  • 1998 PhD (Molecular Oncology), School of Medicine, University of Leeds.

  • 1988 BSc (Hons) Genetics, University of Liverpool.
  • My research is based on the application of cancer proteomics to:



    • identify biomarkers of response to anticancer therapy

    • identify novel therapy targets or therapy strategies

    • investigate the molecular mechanism of action of novel anticancer agents

    V C Hodgkinson, V Agarwal, D ELFadl, J N Fox, P L McManus, T K Mahapatra, P J Kneeshaw, P J Drew, M J Lind, L Cawkwell. Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer. Journal of Proteomics 75: 2745-2752 (2012).


    V C Hodgkinson, D ELFadl, V Agarwal, V Garimella, C Russell, E D Long, J N Fox, P L McManus, T K Mahapatra, P J Kneeshaw, P J Drew, M J Lind, L Cawkwell. Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID? Journal of Proteomics 75: 1276-1283 (2012).


    V C Hodgkinson, D ELFadl, P J Drew, M J Lind,L Cawkwell. Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis. Journal of Proteomics. 74: 698-703 (2011).


    V Agarwal, M J Lind, L Cawkwell. Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand? Cancer Treatment Reviews 37: 533-542 (2011).


    L Smith, O Qutob, M B Watson, A W Beavis, D Potts, K J Welham, V Garimella, M J Lind, P J Drew, L Cawkwell. Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome? Neoplasia 11:1194-1207 (2009).

    Graduate Research Director (Postgraduate Medical Institute).


    Chair, Humber Bridge Research Ethics Committee (NHS Health Research Authority).


    Contact details
    l.cawkwell@hull.ac.uk
    01482 461850

    Update my profile